Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-028-2 | CAS number: 751-83-7
Endpoint summary
Administrative data
Description of key information
ORAL
LD50, rat, combined = 1735 mg/kg bw (95% C.I. 1248 - 2412)
DERMAL
No data are available.
INHALATION
No mortality was observed when 12 rats were exposed by inhalation to an atmosphere that had been saturated at 20°C with the volatile parts of C15-Salz (purity not given) for up to 8 hours.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 1 735 mg/kg bw
Additional information
- Oral LD50 Combined = 1735 mg/kg bw (95% C.I. 1248 - 2412)
ORAL
In an acute oral toxicity study (BASF, 1975), groups of Sprague-Dawley rats (5/sex) were given a single oral dose of C15-Salz (purity not given) in olive oil at doses of 1000, 1470, 2150, 4640, or 6810 mg/kg bw and observed for 14 days.
C15-Salz is of MODERATE Toxicity based on the LD50 in male and female rats.
Clinical signs of toxicity included prone position, apathy, diarrhea, exsiccosis, spastic gait, emaciation, and reddish encrustations around the snout and nose. Pathological examination revealed dilatation of the heart and/or stomach, congestive hyperemia, liquid content of the stomach, diarrhetic content of the intestine, caustic eschar, and intraabdominal adhesions.
DERMAL
No data are available.
INHALATION
In an Inhalation Risk Test (BASF, 1975), totally 12 rats were exposed by inhalation route to an atmosphere that had been saturated at 20°C with the volatile parts of C15-Salz (purity not given) for up to 8 hours. Animals then were observed for 14 days. No deaths occurred; no clinical symptoms and no pathological findings were observed. C15-Salz is classified as being of LOW Toxicity based on lack of any adverse observations under the conditions of this test.
Justification for classification or non-classification
Based on the oral LD50 in rats, C15-Salz has to be classified as “harmful if swallowed” according to the Directive 67/548/EC. According to the GHS criteria, C15 -Salz has to be classified as follows: Acute Oral Toxicity Cat. 4.
There is no need to classify C15-Salz for acute inhalation toxicity according to the Directive 67/548/EC or GHS criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
